Principal Financial Group’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $7.91M | Sell |
4,601,441
-92,681
| -2% | -$159K | ﹤0.01% | 1375 |
|
2025
Q1 | $15.6M | Buy |
4,694,122
+1,047,335
| +29% | +$3.49M | 0.01% | 997 |
|
2024
Q4 | $27M | Sell |
3,646,787
-386,397
| -10% | -$2.86M | 0.01% | 695 |
|
2024
Q3 | $37.9M | Buy |
4,033,184
+1,496,941
| +59% | +$14.1M | 0.02% | 557 |
|
2024
Q2 | $20.3M | Buy |
2,536,243
+530,338
| +26% | +$4.25M | 0.01% | 843 |
|
2024
Q1 | $29.7M | Sell |
2,005,905
-630,422
| -24% | -$9.34M | 0.02% | 684 |
|
2023
Q4 | $21.4M | Sell |
2,636,327
-6,828
| -0.3% | -$55.5K | 0.01% | 828 |
|
2023
Q3 | $12M | Buy |
2,643,155
+772,905
| +41% | +$3.52M | 0.01% | 1119 |
|
2023
Q2 | $13.2M | Sell |
1,870,250
-42,522
| -2% | -$299K | 0.01% | 1103 |
|
2023
Q1 | $11.7M | Buy |
1,912,772
+881,181
| +85% | +$5.38M | 0.01% | 1180 |
|
2022
Q4 | $6.59M | Sell |
1,031,591
-35,841
| -3% | -$229K | 0.01% | 1441 |
|
2022
Q3 | $10.2M | Buy |
1,067,432
+150,749
| +16% | +$1.44M | 0.01% | 1180 |
|
2022
Q2 | $10.1M | Buy |
916,683
+350,025
| +62% | +$3.86M | 0.01% | 1247 |
|
2022
Q1 | $9.44M | Buy |
566,658
+5,071
| +0.9% | +$84.4K | 0.01% | 1406 |
|
2021
Q4 | $10.7M | Buy |
561,587
+14,720
| +3% | +$281K | 0.01% | 1349 |
|
2021
Q3 | $13.5M | Buy |
546,867
+21,784
| +4% | +$537K | 0.01% | 1240 |
|
2021
Q2 | $13.7M | Buy |
525,083
+106,211
| +25% | +$2.76M | 0.01% | 1254 |
|
2021
Q1 | $13.3M | Buy |
418,872
+37,419
| +10% | +$1.18M | 0.01% | 1233 |
|
2020
Q4 | $17.7M | Buy |
381,453
+10,779
| +3% | +$500K | 0.01% | 856 |
|
2020
Q3 | $12.2M | Buy |
370,674
+806
| +0.2% | +$26.5K | 0.01% | 946 |
|
2020
Q2 | $10.2M | Buy |
369,868
+178,760
| +94% | +$4.91M | 0.01% | 1048 |
|
2020
Q1 | $5.72M | Buy |
191,108
+88,858
| +87% | +$2.66M | 0.01% | 1218 |
|
2019
Q4 | $2.83M | Buy |
102,250
+65,635
| +179% | +$1.82M | ﹤0.01% | 1664 |
|
2019
Q3 | $666K | Buy |
36,615
+3,303
| +10% | +$60.1K | ﹤0.01% | 1892 |
|
2019
Q2 | $817K | Buy |
33,312
+4,095
| +14% | +$100K | ﹤0.01% | 1870 |
|
2019
Q1 | $278K | Buy |
29,217
+4,320
| +17% | +$41.1K | ﹤0.01% | 2055 |
|
2018
Q4 | $220K | Sell |
24,897
-4,337
| -15% | -$38.3K | ﹤0.01% | 2107 |
|
2018
Q3 | $329K | Buy |
29,234
+4,108
| +16% | +$46.2K | ﹤0.01% | 2057 |
|
2018
Q2 | $322K | Buy |
+25,126
| New | +$322K | ﹤0.01% | 2063 |
|
2017
Q2 | – | Sell |
-10,172
| Closed | -$76K | – | 2273 |
|
2017
Q1 | $76K | Hold |
10,172
| – | – | ﹤0.01% | 2160 |
|
2016
Q4 | $71K | Buy |
+10,172
| New | +$71K | ﹤0.01% | 2179 |
|
2015
Q3 | – | Sell |
-12,391
| Closed | -$114K | – | 2201 |
|
2015
Q2 | $114K | Buy |
+12,391
| New | +$114K | ﹤0.01% | 2119 |
|